Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
R&D
Biotech
Takeda ends mRNA research pact with Japanese drug discoverer
The partnership with Veritas In Silico kicked off in 2023, with a goal of developing new meds for genetically-defined diseases.
Darren Incorvaia
Apr 14, 2026 9:57am
J&J, Royalty to co-fund $500M autoimmune antibody program
Mar 30, 2026 10:07am
Top 10 pharma R&D budgets of 2025
Mar 30, 2026 3:00am
Fierce Pharma
Novartis pledges nearly $480M to bolster China production, R&D
Mar 23, 2026 10:35am
Pfizer drops another early cancer candidate from Seagen
Mar 19, 2026 12:56pm
Roche inks Nvidia expansion to bolster AI factory
Mar 16, 2026 5:58pm
